Sweden · Delayed Price · Currency is SEK Isofol Medical AB Statistics
Total Valuation
STO:ISOFOL has a market cap or net worth of SEK 167.40 million. The enterprise value is 28.61 million.
| Market Cap | 167.40M |
| Enterprise Value | 28.61M |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ISOFOL has 281.11 million shares outstanding. The number of shares has increased by 20.55% in one year.
| Current Share Class | 281.11M |
| Shares Outstanding | 281.11M |
| Shares Change (YoY) | +20.55% |
| Shares Change (QoQ) | +61.29% |
| Owned by Insiders (%) | 9.07% |
| Owned by Institutions (%) | 9.68% |
| Float | 226.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.53 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.80
| Current Ratio | 6.80 |
| Quick Ratio | 6.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55,896.00 |
Financial Efficiency
Return on equity (ROE) is -51.49% and return on invested capital (ROIC) is -33.01%.
| Return on Equity (ROE) | -51.49% |
| Return on Assets (ROA) | -27.70% |
| Return on Invested Capital (ROIC) | -33.01% |
| Return on Capital Employed (ROCE) | -46.10% |
| Weighted Average Cost of Capital (WACC) | 9.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -9.08M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.91% in the last 52 weeks. The beta is 0.92, so STO:ISOFOL's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -71.91% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 28.59 |
| Average Volume (20 Days) | 401,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -41.91M |
| Operating Income | -55.90M |
| Pretax Income | -54.49M |
| Net Income | -54.49M |
| EBITDA | -55.89M |
| EBIT | -55.90M |
| Earnings Per Share (EPS) | -0.29 |
Balance Sheet
The company has 138.79 million in cash and n/a in debt, with a net cash position of 138.79 million or 0.49 per share.
| Cash & Cash Equivalents | 138.79M |
| Total Debt | n/a |
| Net Cash | 138.79M |
| Net Cash Per Share | 0.49 |
| Equity (Book Value) | 120.62M |
| Book Value Per Share | 0.43 |
| Working Capital | 121.25M |
Cash Flow
| Operating Cash Flow | -48.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ISOFOL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.55% |
| Shareholder Yield | -20.55% |
| Earnings Yield | -32.55% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |